Johnson & JohnsonJNJ
JNJ
0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 9 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
151% more first-time investments, than exits
New positions opened: 435 | Existing positions closed: 173
25% more call options, than puts
Call options by funds: $2.64B | Put options by funds: $2.11B
5% more funds holding
Funds holding: 3,831 [Q3] → 4,011 (+180) [Q4]
1.66% more ownership
Funds ownership: 70.16% [Q3] → 71.82% (+1.66%) [Q4]
6% less capital invested
Capital invested by funds: $273B [Q3] → $256B (-$16.5B) [Q4]
23% less funds holding in top 10
Funds holding in top 10: 189 [Q3] → 145 (-44) [Q4]
30% less repeat investments, than reductions
Existing positions increased: 1,330 | Existing positions reduced: 1,907
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$152
4%
downside
Avg. target
$165
5%
upside
High target
$181
15%
upside
9 analyst ratings
4 positive
44%
5 neutral
56%
0 negative
0%
Barclays Matt Miksic 44% 1-year accuracy 18 / 41 met price target | 4%upside $165 | Equal-Weight Maintained | 17 Apr 2025 |
Raymond James Jayson Bedford 39% 1-year accuracy 11 / 28 met price target | 4%upside $164 | Outperform Maintained | 16 Apr 2025 |
Morgan Stanley Terence Flynn 33% 1-year accuracy 7 / 21 met price target | 7%upside $169 | Equal-Weight Maintained | 16 Apr 2025 |
RBC Capital Shagun Singh 33% 1-year accuracy 22 / 66 met price target | 15%upside $181 | Outperform Reiterated | 16 Apr 2025 |
B of A Securities Tim Anderson 47% 1-year accuracy 7 / 15 met price target | 1%upside $159 | Neutral Maintained | 10 Apr 2025 |
Financial journalist opinion
Based on 126 articles about JNJ published over the past 30 days
Positive
Seeking Alpha
3 hours ago
Two Stocks To Consider During Market Unrest To Provide Income Stability
Investors should remain calm amid market volatility and consider buying during price dips, with 2025 expected to see more turbulence. Kenvue's strong brand portfolio and solid liquidity offer price stability and a 3.59% dividend yield, despite potential headwinds from tariffs and economic slowdown. Altria Group, with its 7% yield and Dividend King status, provides stability and potential upside during economic uncertainty, leveraging its pricing power and recession-proof products.
Neutral
PRNewsWire
1 day ago
Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA
TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2) Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study show potential of TAR-200 monotherapy in patients with papillary-only, high-risk non-muscle invasive bladder cancer RARITAN, N.J. , April 21, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26-29 in Las Vegas.
Positive
FXEmpire
1 day ago
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Neutral
The Motley Fool
2 days ago
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government
In 2011, following the difficulty caused by the Great Recession, S&P Global Ratings (formerly Standard & Poor's) downgraded the long-term credit outlook of the United States from its highest designation of AAA to AA+, citing budgetary issues. Fitch once again downgraded U.S. credit in 2023 and Moody's recently suggested it's contemplating a similar move.
Positive
The Motley Fool
3 days ago
3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now
Dividend stocks can be fantastic investments. The best ones pay an attractive and growing stream of dividend income while also delivering healthy stock price appreciation over the long term.
Positive
PYMNTS
4 days ago
Johnson & Johnson: 15% of AI Use Cases Deliver 80% of Value
Johnson & Johnson reportedly found that 10% to 15% of artificial intelligence use cases deliver 80% of the value.
Positive
24/7 Wall Street
4 days ago
One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs
Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential.
Neutral
WSJ
4 days ago
Johnson & Johnson Pivots Its AI Strategy
The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or underdelivering.
Positive
24/7 Wall Street
5 days ago
3 High-Yield Dividend All-Stars to Buy Right Now
The good news for investors seeking high-yield dividend stocks to buy right now is that there are a number of top options for investors to consider in the high-yield dividend world.
Neutral
Zacks Investment Research
5 days ago
Here's How You Should Play JNJ Stock After Q1 Earnings Beat
Those who own JNJ stock may stay invested for some time to see how the company achieves growth in 2025 amid the various challenges.
Charts implemented using Lightweight Charts™